Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders
News
Four international teams awarded £4.7m to investigate heart and circulatory diseases
These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally
Innovate UK awards ten projects over £6m to develop new clinical tools for dementia
Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year
Researchers reveal protein found in human sweat could protect against Lyme disease
The bacterial infection transmitted by ticks affects nearly half a million people in the US every year
Parkinson’s UK grants funding of up to nearly £450,000 to four new research projects
The globally fast-growing progressive neurological condition affects around 153,000 people in the UK
New study reveals neurological conditions as leading cause of ill health worldwide
In 2021, neurological conditions, including Alzheimer’s disease, affected approximately 3.4 billion people globally
Researchers suggest treatments for rare diseases could reduce burden of kidney disease
Rare kidney diseases are a group of conditions which account for over 5% of people living with chronic kidney disease
KCL researchers develop pipeline to create customisable cell culture device creations
The SOL3D pipeline addresses research challenges in relation to equipment, expertise and cost
ALS Association partners with myTomorrows to improve clinical trial accessibility
The fatal motor neurone disease currently does not have a cure available to treat patients
Birmingham’s VR-assisted training centre for excellence to support future vaccine makers
The centre will deliver free training, outreach materials and programmes
AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland
Up to 20% of prostate cancer cases are classified as castration-resistant
NIHR reveals phase 1/2 trial to evaluate an investigational vaccine for mpox in the UK
More than 3,700 cases of mpox have been identified in the UK since May 2022
NHS to roll out AI to improve waiting times and reduce missed appointments
Every year, missed hospital appointments are estimated to cost the NHS £1.2bn
Roche partners with Cardiff researchers to uncover new research into dementia
Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions
Swedish researchers develop new AI computer model to detect lymphatic cancer
In the study, the Lymphoma Artificial Reader System accurately detected 90% of lymphatic cancers
